Objective
This annual conference aims at keeping legal practitioners working
with the pharmaceutical sector up-to-date on the latest relevant
regulatory developments, legislative initiatives and case law. A
particular focus will be on implications for the sector of recent EU
activities in the fields of competition law, intellectual property, data
protection and privacy as well as pharmaceutical law.
Key topics
Competition law and patents
- Reverse payment settlements in the US and in
Europe and current activities from the European Commission in the field
of competition law
- Interim and cross-border injunctions against infringement of pharmaceutical patents
- Preparing for the EU unitary patent system: update on recent developments
Data protection and privacy
- Access to clinical trials data: the General Court decision in InterMune (T-73/13R)
- Proposal for modification of the General Data Protection Regulation (COM(2012)11): implications for the life science sector
- Cloud computing health services and data protection
EU pharmaceutical law round-up
- Update on EU legislative proposals: clinical trials, in vitro diagnostics, orphan drugs
- Major developments in the fight against falsified medicinal products
- Drug device combination products and data exclusivity
- Off-label use and the CJEU case Novartis Pharma v Apozyt (C-535/11)
- Orphan medicinal products and the recent decision in Laboratoires CTRS (T-301/12)
Who should attend?
In-house
counsel and legal or patent advisers in pharmaceutical companies;
lawyers in private practice dealing with pharmaceuticals and medical
devices; lawyers in national ministries and authorities dealing with
regulation of the sector.
Gebühren in €:
|
Standard
|
EU und ERA Mitstifter
|
Junge Juristen und andere Gruppen
|
|
Registrierung
|
|
|
|
|
|
Mehr Informationen zu den Vergünstigungen
Frühzeitige Anmeldungen
10 % bis 27.01.2014
Mögliche Ermässigungen
25 % - Für junge Juristen bis einschließlich 30 Jahre (wichtig: bitte Kopie des Personalausweises mitschicken); hauptberufliche Mitarbeiter von Universitäten oder vergleichbaren wissenschaftlichen Einrichtungen; Mitarbeiter karitativer Organisationen
40 % - Für Beschäftigte der EU;
für Beschäftigte von Mitstiftern der ERA (Bulgarien, Deutschland und die deutschen Länder, Finnland, Frankreich, Griechenland, Irland, Italien, Kroatien, Litauen, Luxemburg, Malta, Niederlande, Österreich, Polen, Portugal, Rumänien, Schottland, Schweden, Slowenien, Slowakei, Spanien, Tschechien, Ungarn, Vereinigtes Königreich, Zypern, Stadt Trier)